ments are taken into account in the decision about the treatment of selected MS patients, then immunosuppression is thoroughly justified.The restrictions I have given imply, nevertheless, that at the present time one cannot advocate the general application of immunosuppression as a standard form of MS treatment.However, in the framework of strictly controlled and monitored clinical trials the effects of immunosuppression in MS patients should be studied further, and this may not only be of some benefit for, I hope, an increasing number of patients, but may eventually also add to our knowledge about the pathological processes underlying this disease.
No takes yet. Share an insight, caveat, or question.
Hughes et al. (1977) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: